| Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, and Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, depreciation and amortization, operating profit, and interest expense for the three months ended February 28, 2023 and 2022:
|
|
|
|
|
|
|
|
|
|
|
For the three months ended February 28, |
|
|
|
2023 |
|
|
2022 |
|
Net revenue: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
7,561,518 |
|
|
$ |
7,157,486 |
|
PrepaCyte CB |
|
|
32,200 |
|
|
|
18,200 |
|
Public cord blood banking |
|
|
230,697 |
|
|
|
82,845 |
|
Total net revenue |
|
$ |
7,824,415 |
|
|
$ |
7,258,531 |
|
Cost of sales: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,687,250 |
|
|
$ |
1,714,672 |
|
PrepaCyte CB |
|
|
17,122 |
|
|
|
30,658 |
|
Public cord blood banking |
|
|
362,992 |
|
|
|
357,872 |
|
Total cost of sales |
|
$ |
2,067,364 |
|
|
$ |
2,103,202 |
|
Operating profit: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,807,693 |
|
|
$ |
1,765,213 |
|
PrepaCyte CB |
|
|
8,133 |
|
|
|
(19,403 |
) |
Public cord blood banking |
|
|
(132,655 |
) |
|
|
(275,388 |
) |
Total operating profit |
|
$ |
1,683,171 |
|
|
$ |
1,470,422 |
|
Depreciation and amortization: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
273,539 |
|
|
$ |
270,862 |
|
PrepaCyte CB |
|
|
6,945 |
|
|
|
6,944 |
|
Public cord blood banking |
|
|
360 |
|
|
|
360 |
|
Total depreciation and amortization |
|
$ |
280,844 |
|
|
$ |
278,166 |
|
Interest expense: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
466,231 |
|
|
$ |
306,095 |
|
PrepaCyte CB |
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
Total interest expense |
|
$ |
466,231 |
|
|
$ |
306,095 |
|
|
|
|
|
|
|
|
The following table shows the assets by segment as of February 28, 2023 and November 30, 2022:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
|
February 28, 2023 |
|
|
November 30, 2022 |
|
Assets: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell
service |
|
$ |
56,298,385 |
|
|
$ |
54,849,697 |
|
PrepaCyte CB |
|
|
140,439 |
|
|
|
176,546 |
|
Public cord blood banking |
|
|
9,695,211 |
|
|
|
9,861,811 |
|
Total assets |
|
$ |
66,134,035 |
|
|
$ |
64,888,054 |
|
|